ANAB vs GILD: Which Stock is Better?
Side-by-side comparison of Anaptysbio Inc and Gilead Sciences Inc in 2026
ANAB
Anaptysbio Inc
$55.67
GILD
Gilead Sciences Inc
$134.43
Key Metrics Comparison
| Metric | ANAB | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.69B | $165.99B | GILD |
| P/E Ratio | N/A | 18.19 | GILD |
| EPS (TTM) | $N/A | $7.35 | GILD |
| Revenue Growth | -0.1% | 0.0% | GILD |
| Gross Margin | 44.6% | 79.4% | GILD |
Analyze ANAB
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANAB or GILD a better investment?
Comparing ANAB and GILD: Anaptysbio Inc has a market cap of $1.69B while Gilead Sciences Inc has $165.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANAB and GILD?
ANAB (Anaptysbio Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANAB or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANAB or GILD?
GILD has higher revenue growth at 0.0% vs -0.1% for ANAB.
Which company is more profitable: ANAB or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 79.4% compared to 44.6% for ANAB.
Which is the larger company: ANAB or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $165.99B compared to $1.69B for ANAB.
Should I buy ANAB or GILD in 2026?
Both ANAB and GILD have investment merit. ANAB trades at $55.67 while GILD trades at $134.43. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANAB and GILD stock?
Key differences: Market Cap ($1.69B vs $165.99B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (44.6% vs 79.4%).